| Literature DB >> 16962434 |
Alexander K C Leung1, W Lane M Robson, Alexander G Leong.
Abstract
Herpes zoster is caused by reactivation of latent varicella-zoster virus that resides in a dorsal root ganglion. Herpes zoster can develop any time after a primary infection. Because varicella vaccine is a live attenuated virus, herpes zoster can develop in a vaccine recipient. The incidence of herpes zoster among vaccine recipients is about 14 cases per 100,000 person-years. In young children, herpes zoster has a predilection for areas supplied by the cervical and sacral dermatomes. The most common complications are secondary bacterial infection, depigmentation, and scarring. Although the diagnosis of herpes zoster is based on a distinct clinical appearance, viral DNA analysis of the lesion by polymerase chain reaction or restriction fragment length polymorphism is necessary to differentiate wild from vaccine-type viruses. Acyclovir is the treatment of choice for herpes zoster.Entities:
Mesh:
Substances:
Year: 2006 PMID: 16962434 DOI: 10.1016/j.pedhc.2006.01.004
Source DB: PubMed Journal: J Pediatr Health Care ISSN: 0891-5245 Impact factor: 1.812